NCT05363709View on ClinicalTrials.gov

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

February 15, 2028

Study Completion Date

February 15, 2028

Conditions

HPVOropharyngeal Cancer

Interventions

DRUG

Balstilimab

Given by Vein (IV)

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Agenus Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER